UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051733
Receipt number R000058958
Scientific Title Evaluating the efficacy of transcranial Static Magnetic Stimulation in the rehabilitation of hemiplegic stroke patients. a randomized, double-blind, crossover trial
Date of disclosure of the study information 2023/07/27
Last modified on 2023/07/27 21:32:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluating the efficacy of transcranial Static Magnetic Stimulation in the rehabilitation of hemiplegic stroke patients

Acronym

Evaluating the efficacy of tSMS in the rehabilitation of hemiplegic stroke patients

Scientific Title

Evaluating the efficacy of transcranial Static Magnetic Stimulation in the rehabilitation of hemiplegic stroke patients. a randomized, double-blind, crossover trial

Scientific Title:Acronym

Evaluating the efficacy of tSMS in the rehabilitation of hemiplegic stroke patients. a randomized, double-blind, crossover trial

Region

Japan


Condition

Condition

hemiplegic stroke patient

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Non-invasive brain stimulation (NIBS) has attracted attention in recent years. Transcranial static magnetic stimulation (tSMS) is a new NIBS that has been shown to suppress brain excitability by simply placing a powerful permanent magnet on the surface of the head. tSMS does not cause seizures or burns. tSMS does not cause seizures or burns and does not require special equipment because it uses only permanent magnets.
tSMS does not require special equipment and can be used in conjunction with rehabilitation during stimulation. However, it has not been determined whether tSMS promotes functional recovery of motor paralysis after stroke. Therefore, the purpose of this study was to evaluate the clinical efficacy of tSMS in improving the functional recovery of post-stroke motor paralysis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I


Assessment

Primary outcomes

The duration of the first and second interventions will be 10 days and will be evaluated using motor function tests of the upper limb extremity.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

The intervention is a condition (tSMS combined therapy) in which a small neodymium magnet is set in the cephalic surface of the contralesional primary motor area (C3 or C4 region) for 20 minutes based on the International 10-20 system method during a 60-minute rehabilitation. Washout period is performed for 2 days, followed by placement of a stainless steel block in the same way (sham combined therapy).

Interventions/Control_2

After the sham combined therapy, a washout period of 2 days is allowed and the tSMS combined therapy is administered.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with a first unilateral stroke between 30 and 90 days after onset, with Brunnstrom recovery level 3-5 of the paralyzed side of the hand (sufficient active flexion of the hand).

Key exclusion criteria

The patient has significant cognitive decline or higher brain dysfunction, active systemic or psychiatric disease, or intracranial metal, pacemaker, cervical spine, or other conditions that the treating physician determines to be of clinical or safety concern.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Yoshihiro
Middle name
Last name Yukawa

Organization

Department of Rehabilitation, Wakayama Professional University of Rehabilitation,

Division name

Faculty of Health Sciences, DepartmentDepartment of Rehabilitation

Zip code

640- 8222

Address

3-1 Minato-Honcho, Wakayama City, Wakayama Prefecture

TEL

073-435-4888

Email

yukawa@kyowa.ac.jp


Public contact

Name of contact person

1st name Yoshihiro
Middle name
Last name Yukawa

Organization

Department of Rehabilitation, Wakayama Professional University of Rehabilitation,

Division name

Faculty of Health Sciences, Department of Rehabilitation

Zip code

640- 8222

Address

3-1 Minato-Honcho, Wakayama City, Wakayama Prefecture

TEL

073-435-4888

Homepage URL


Email

yukawa@kyowa.ac.jp


Sponsor or person

Institute

Department of Rehabilitation, Wakayama Professional University of Rehabilitation,

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

N/A

Address

N/A

Tel

N/A

Email

N/A


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 04 Month 01 Day

Date of IRB

2022 Year 03 Month 06 Day

Anticipated trial start date

2022 Year 03 Month 10 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 07 Month 27 Day

Last modified on

2023 Year 07 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000058958


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name